Shanks v Unilever plc
An employee inventor was entitled to compensation under section 40 of the Patents Act 1977, because the patents for his invention had been of outstanding benefit to his employer, having regard to the size and nature of its undertaking.
Facts
Professor Shanks, an employee of a research company in the Unilever group, invented a glucose measuring device which was patented. The patents were assigned within the group, and Unilever made about 24 million pounds from licensing them, mainly to companies making blood glucose testing strips for diabetics. Under section 40 of the 1977 Act, an employee is entitled to compensation where a patent for an invention made by him in the course of his duties is, having regard to the size and nature of the employer's undertaking, of outstanding benefit to the employer. The lower courts held that the benefit was not outstanding, given the size of the Unilever group.
Legal principle
The Supreme Court, in a judgment given by Lord Kitchin, unanimously allowed Professor Shanks's appeal. The question whether a patent was of outstanding benefit, meaning something special or out of the ordinary, had to be considered in relation to the employer's undertaking, which here was the research company, and the benefit was outstanding because it was much greater than the benefit from other patents and was not merely a small fraction of the profits of the whole group. It was relevant that the patents had generated substantial income for little cost or risk. The court awarded compensation of two million pounds, representing a fair share of the benefit, adjusted for inflation.
Related cases on patents: patentability and validity
- Aerotel Ltd v Telco Holdings Ltd; Macrossan's Application [2006] EWCA Civ 1371, [2007] RPC 7
- Biogen Inc v Medeva plc [1997] RPC 1
- Conor Medsystems Inc v Angiotech Pharmaceuticals Inc [2008] UKHL 49, [2008] RPC 28
- Emotional Perception AI Ltd v Comptroller General of Patents, Designs and Trade Marks [2026] UKSC 3
- Generics (UK) Ltd v H Lundbeck A/S [2009] UKHL 12, [2009] RPC 13
- Human Genome Sciences Inc v Eli Lilly & Co [2011] UKSC 51, [2012] RPC 6
- Merrell Dow Pharmaceuticals Inc v HN Norton & Co Ltd [1996] RPC 76
- Oliver Brüstle v Greenpeace eV Case C-34/10, [2011] ECR I-9821
Studying intellectual property law? Our tutors help you understand and apply cases like this in essays, problem questions and exams. Request a quote or browse our law notes.
This summary is for study and revision and is not legal advice. Although our case summaries are checked for accuracy, we do not guarantee that they are free from errors or omissions. Always read the full judgment for the court's reasoning.
